Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Saturday
May 07
08:45 - 10:00
Auditorium 11
Soft tissue sarcoma: Brachytherapy and/or EBRT or IORT - Current evidence
Csaba Polgar, Hungary;
Vratislav Strnad, Germany
Debate
Brachytherapy
09:27 - 09:47
Value of IORT
Falk Röder, Austria
SP-0032

Abstract

Value of IORT
Authors:

Falk Roeder1

1University of Salzburg, Radiation Oncology, Salzburg, Austria

Show Affiliations
Abstract Text

In this talk, we will summarize the current evidence for IORT as a boost strategy preceeded or followed by EBRT in adult soft-tissue sarcomas of the extremity, trunk and retroperitoneal space and discuss the pros and cons of IORT in certain clinical situations. We will further present technical and practical considerations for state of the art performance of IORT based on the recently pupblished ESTRO-ACROP guideline for IORT in soft-tissue sarcoma, as well as further directions of IORT for example image-guided IORT.